Showing results (1191-1200 of 2,524) with videos related to

Sort By:
Pageof 253
Inflammopharmacology|June 15, 2026
Epigallocatechin-3-gallate (EGCG) as a molecular chaperone and network rebalancer in neurodegenerative diseasesHusni Farah, Media Hamed Ahmed, Shaker Al-Hasnaawei, et al.
Inflammopharmacology|July 17, 2023
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVIDTamás Constantin, Tamás Pék, Zsuzsanna Horváth, et al.
Inflammopharmacology|July 17, 2023
Neuromodulatory effect of vardenafil on aluminium chloride/D-galactose induced Alzheimer's disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescenceHeba H Awad, Mahmoud A Desouky, Alaa Zidan, et al.
Inflammopharmacology|August 4, 2023
PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in ratsHeba A Farid, Rabab H Sayed, Marwa El-Sayed El-Shamarka, et al.
Inflammopharmacology|July 26, 2023
Methotrexate is associated with decreased total thyroxine in patients with rheumatoid arthritisShu-Lin Chen, Qiang Xu, Chang-Song Lin
Inflammopharmacology|August 4, 2023
Acyclic monoterpenoid-rich essential oil of Cymbopogon distans mitigates skin inflammation: a chemico-pharmacological studyDivya Bhatt, Swati Singh, Munmun Kumar Singh, et al.
Inflammopharmacology|July 28, 2023
The effects of pomegranate consumption on inflammatory and oxidative stress biomarkers in adults: a systematic review and meta-analysisHossein Bahari, Hossein Rafiei, Kian Goudarzi, et al.
Inflammopharmacology|July 27, 2023
Ameliorative effect of montelukast against STZ induced diabetic nephropathy: targeting HMGB1, TLR4, NF-κB, NLRP3 inflammasome, and autophagy pathwaysAhmed M Awad, Sally L Elshaer, Rajashekhar Gangaraju, et al.
Inflammopharmacology|July 11, 2023
Intranasal inorganic cerium oxide nanoparticles ameliorate oxidative stress induced motor manifestations in haloperidol-induced parkinsonismMohammad, Urooj Ahmed Khan, Zoya Saifi, et al.
Inflammopharmacology|July 8, 2023
Pharmaceutical aspects of novel CGRP inhibitors used in the prophylaxis and treatment of migraineSandhya Jinesh
Pageof 253